Company intelligence / Profile preview

Fangyuan Capital

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

Fangyuan Capital is a specialized healthcare-focused investment firm and boutique investment bank headquartered in China. The firm provides venture capital, private equity, and financial advisory services specifically tailored to the life sciences, biotechnology, and medical technology sectors. Fangyuan Capital is recognized for its deep industry expertise and its role in facilitating cross-border transactions and financing for emerging Chinese biotech companies. By leveraging a broad network of clinical experts and industry partners, the firm provides strategic support to its portfolio companies to drive innovation and growth in the global healthcare market.

Industry: Investors

Beyond the preview

Go deeper on Fangyuan Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fangyuan Capital.

Explore the full profile